T1	Visit 0 17	Ambulatory status
T2	Visit 19 29	outpatient
R1	Subsumes Arg1:T1 Arg2:T2	
T3	Temporal 31 49	at time of consent
R2	Has_temporal Arg1:T1 Arg2:T3	
T4	Value 55 66	10-55 years
T5	Person 51 54	Age
R3	Has_value Arg1:T5 Arg2:T4	
T6	Condition 90 114	Autism Spectrum Disorder
T7	Measurement 116 118	IQ
T8	Value 119 146	greater than or equal to 70
T9	Measurement 172 220	Children's Yale-Brown Obsessive Compulsive Scale
T10	Value 154 168	greater than 8
R4	Has_value Arg1:T9 Arg2:T10	
T11	Drug 230 253	psychoactive medication
T12	Negation 222 229	Free of
R5	Has_negation Arg1:T11 Arg2:T12	
T13	Temporal 258 266;268 277	at least one month
T14	Temporal 258 266;294 303	at least two weeks
T15	Temporal 258 266;342 351	at least five days
T16	Drug 282 292	fluoxetine
T17	Drug 314 319	SSRIs
T18	Drug 324 336	neuroleptics
*	OR T17 T18
T19	Scope 314 336	SSRIs and neuroleptics
T20	Drug 356 366	stimulants
T21	Temporal 367 388	prior to MRI scanning
T22	Drug 453 478	anticonvulsant medication
T23	Condition 483 499	seizure disorder
R7	AND Arg1:T22 Arg2:T23	
R8	Has_temporal Arg1:T20 Arg2:T15	
T24	Temporal 414 439	greater than three months
T25	Qualifier 400 412	stable doses
R9	Subsumes Arg1:T25 Arg2:T24	
T26	Scope 258 366	at least: one month for fluoxetine; two weeks for other SSRIs and neuroleptics; and five days for stimulants
R10	Has_temporal Arg1:T26 Arg2:T21	
R11	Has_scope Arg1:T11 Arg2:T26	
R12	Has_qualifier Arg1:T22 Arg2:T25	
R13	Has_value Arg1:T7 Arg2:T8	
R6	Has_temporal Arg1:T16 Arg2:T13	
R14	Has_temporal Arg1:T19 Arg2:T14	
*	OR T20 T19 T16
T27	Negation 390 399	excepting
R15	Has_negation Arg1:T22 Arg2:T27	
R16	AND Arg1:T11 Arg2:T22	
T28	Qualifier 68 86	Clinical diagnosis
R17	Has_qualifier Arg1:T6 Arg2:T28	
